Metformin monotherapy versus dual therapy with metformin and a dipeptidyl peptidase-IV inhibitor for treatment of type 2 diabetes mellitus: a systematic review and meta-analysis

被引：0
|
作者：
Tobin-Schnittger, P. [1 ]
Ong, G. [2 ]
O'Brien, T. [2 ,4 ]
Liew, A. [2 ,3 ,4 ]
机构：
[1] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Portiuncula Univ Hosp, Ballinasloe, Ireland
[4] Natl Univ Ireland Galway, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P75
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [41] The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Wu, H. -D.
    Zhang, J. -J.
    Zhou, B. -J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 275 - 282
  • [42] Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Abrilla, Aedrian A.
    Pajes, A. Nico Nahar I.
    Jimeno, Cecilia A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [43] Metformin versus insulin for gestational diabetes mellitus: a meta-analysis
    Zhao, Li-Ping
    Sheng, Xiao-Yan
    Zhou, Shuang
    Yang, Ting
    Ma, Ling-Yue
    Zhou, Ying
    Cui, Yi-Min
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (05) : 1224 - 1234
  • [44] Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis
    Kamrul-Hasan, A. B. M.
    Dutta, Deep
    Nagendra, Lakshmi
    Sharma, Meha
    Patra, Shinjan
    Bhattacharya, Saptarshi
    MEDICINE, 2024, 103 (28) : e38870
  • [45] Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis
    Memon, Hamda
    Abdulla, Fatima
    Reljic, Tea
    Alnuaimi, Saif
    Serdarevic, Fadila
    Asimi, Zelija Velija
    Kumar, Ambuj
    Semiz, Sabina
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 202
  • [46] Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Gallwitz, Baptist
    IDRUGS, 2008, 11 (12) : 906 - 917
  • [47] Sitagliptin: A dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Miller, Shannon A.
    St. Onge, Erin L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1336 - 1343
  • [48] Metformin for the Prevention of Prediabetes Progression to Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Ghosal, Samit
    Tippisetty, Surekha
    Polisetti, Subhadra
    Seshadri, Krishna G.
    CLINICAL DIABETOLOGY, 2024, 13 (04): : 233 - 241
  • [49] SGLT2 Inhibitors versus Sulfonylureas as Add-On Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Umer, Muhammed
    Salman, Ali
    Nadeem, Shahrukh
    Iqbal, Abiha
    Tashrifwala, Fatema
    Paryani, Neha Saleem
    Ali, Eman
    Kumar, Jai
    Maniya, Muhammad Talha
    Asad, Dayab
    CIRCULATION, 2023, 148
  • [50] E3024 is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Yasuda, Nobuyuki
    Nagakura, Tadashi
    Inoue, Takashi
    Yamazaki, Kazuto
    Katsutani, Naruo
    Takenaka, Osamu
    Clark, Richard
    Matsuura, Fumiyoshi
    Emori, Eita
    Yoshikawa, Seiji
    Kira, Kazunobu
    Okada, Toshimi
    Ikuta, Hironori
    Saeki, Takao
    Asano, Osamu
    Tanaka, Isao
    DIABETES, 2006, 55 : A349 - A349
12345